| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 09/12/2002 | US20020128476 Inhibitors of cysteine protease |
| 09/12/2002 | US20020128465 Charge tags and the separation of nucleic acid molecules |
| 09/12/2002 | US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants |
| 09/12/2002 | US20020128458 Can be used in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/12/2002 | US20020128457 Nucleotide sequences coding enzymatic polypeptides for use in generation of pyrimidine nucleic acids |
| 09/12/2002 | US20020128456 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of fungal infections |
| 09/12/2002 | US20020128221 Glycosyltransferase vectors for treating cancer |
| 09/12/2002 | US20020128215 Polymorphisms of the NAT-2 gene which can be involved in drug metabolism and various disorders; pharmacogenetics |
| 09/12/2002 | US20020128202 Stimulation of bone growth with thrombin peptide derivatives |
| 09/12/2002 | US20020128201 Tumor antigen |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128190 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/12/2002 | US20020128189 Ubiquitination of the transcription factor E2A |
| 09/12/2002 | US20020128188 For identifying enzyme proteins that are related to helicases, recombinant DNA, and protein production; gene therapy; medical diagnosis; transgenic animals |
| 09/12/2002 | US20020128187 Novel nucleic acids and polypeptides |
| 09/12/2002 | US20020128166 Detergents comprising cellulases |
| 09/12/2002 | US20020127724 Expression vector for use as tool in gene analysis and engineering |
| 09/12/2002 | US20020127696 Nucleotide sequences coding polypeptides for use in the generation of preferential mucopolysaccharides |
| 09/12/2002 | US20020127695 Enzymatic polypeptide for use in detergent and stain removal |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127692 Enzymatic polypeptide for use in the treatment of viral infections, cancer, inflammation, brain disorders and asthma |
| 09/12/2002 | US20020127691 Enzymatic protein for treating inflammation, thrombosis andrestenosis |
| 09/12/2002 | US20020127688 Detecting modulators of enzymes associated with transcriptional activities; obtain cells, incubate with modulators, monitor adjustment in enzyme activities |
| 09/12/2002 | US20020127686 Can be utilized for ester hydrolysis reaction, ester synthesis reaction, ester interchange reaction |
| 09/12/2002 | US20020127685 21908 and 21911, human guanylate kinase family members and uses thereof |
| 09/12/2002 | US20020127684 Novel cark protein and nucleic acid molecules and uses therefor |
| 09/12/2002 | US20020127683 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/12/2002 | US20020127682 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 09/12/2002 | US20020127681 Enzymatic protein for use in treatment of diarrhea |
| 09/12/2002 | US20020127680 62112, a novel human dehydrogenase and uses thereof |
| 09/12/2002 | US20020127679 Used in industrial production of (S)-4-halo-3-hydroxybutyrate ester |
| 09/12/2002 | US20020127678 Enzymatic polypeptide for use in the generation threonine for use in human medicines and nutrients |
| 09/12/2002 | US20020127677 Erythrose reductase, its cDNA and cell which the cDNA express |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127672 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/12/2002 | US20020127670 Riboflavin synthase genes and enzymes and methods of use |
| 09/12/2002 | US20020127664 Protein for use in the generation of bronchodilating agent, pesticides, fungicide, herbicides and for use in the treatment of diabetes |
| 09/12/2002 | US20020127663 Nucleotide sequences coding enzymatic polypeptide for use in human generation of amino acids for use in human therapeutics and animal nutrients |
| 09/12/2002 | US20020127656 DNA repair polypeptides and methods of use |
| 09/12/2002 | US20020127655 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha 1-2 fucosyltransferase and uses thereof |
| 09/12/2002 | US20020127646 CD38 modulated chemotaxis |
| 09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |
| 09/12/2002 | US20020127641 Proteases from gram-positive organisms |
| 09/12/2002 | US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/12/2002 | US20020127633 Microorganism for use in the generation of preferential antibiotics |
| 09/12/2002 | US20020127623 Detecting preferential particles in sample; obtain preferential fusion protein, join to support, incubate with sample, detect confromational changes associate with bound protein |
| 09/12/2002 | US20020127621 KUZ, a novel family of metalloproteases |
| 09/12/2002 | US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/12/2002 | US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders |
| 09/12/2002 | US20020127570 Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates |
| 09/12/2002 | US20020127550 Nucleic acid sequences and methods for identifying compounds that affect rna/rna binding protein interactions and mrna functionality |
| 09/12/2002 | US20020127538 Modifications of the VEGF receptor-2 protein and methods of use |
| 09/12/2002 | US20020127537 Herbicide target genes and methods |
| 09/12/2002 | US20020127299 For producing distilled liquors having an excellent flavor by the use of yeast into which a ferulic acid decarboxylase gene has been introduced |
| 09/12/2002 | US20020127247 Modified clostridial neurotoxins with altered biological persistence |
| 09/12/2002 | US20020127226 Tyrosine phosphatase receptor protein- tenascin ligand complex |
| 09/12/2002 | US20020127220 Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract- |
| 09/12/2002 | US20020127219 A polypeptide selected from lysosomal enzymes and lysosomal enzyme activators, consist of at least one introduced glycosylation site as compared to a corresponding parent enzyme or activator |
| 09/12/2002 | US20020127218 Phytase variants |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127214 RAC-protein kinase as therapeutic agent or in diagnostics |
| 09/12/2002 | US20020127212 Use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 09/12/2002 | US20020127199 Novel nucleic acids and polypeptides |
| 09/12/2002 | DE10111676A1 Erhöhung des Vitamin-E-Gehalts in Organismen durch Erhöhung der Tyrosinaminotransferase-Aktivität Increasing the vitamin E content in organisms by increasing the tyrosine aminotransferase activity |
| 09/12/2002 | DE10110350A1 New nucleic acid encoding part of a mitogenic protein kinase, useful for treating e.g. acquired immune deficiency syndrome and for drug screening, also related peptide |
| 09/12/2002 | DE10109166A1 Avilamycin-Derivate Avilamycin derivatives |
| 09/12/2002 | DE10063387A1 New elongase gene extends 16, 18 and 20 carbon fatty acids, useful to manipulate plants to produce polyunsaturated fatty acids for the foodstuffs, cosmetics and pharmaceutical industries |
| 09/12/2002 | CA2442524A1 Matrix stabilized enzyme crystals and methods of use |
| 09/12/2002 | CA2440358A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 09/12/2002 | CA2440092A1 Protein c variants |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439934A1 Use of protein histidine phosphatase |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2439684A1 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene |
| 09/12/2002 | CA2439454A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/12/2002 | CA2439176A1 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| 09/12/2002 | CA2438375A1 Plant cell having animal-type sugar chain adding function |
| 09/12/2002 | CA2437398A1 Molecules for disease detection and treatment |
| 09/12/2002 | CA2436815A1 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | CA2434601A1 Methods for specifically inhibiting histone deacetylase-4 |
| 09/12/2002 | CA2428798A1 Fen-1 endonucleases from archaeoglobus veneficus |
| 09/11/2002 | EP1239047A2 Method for producing proteins |
| 09/11/2002 | EP1239042A1 Transposase and method of gene modification |
| 09/11/2002 | EP1238275A1 Characterization of hybridized polymer molecules based on monomer-interface interactions |
| 09/11/2002 | EP1238095A2 Compositions and methods for caspase-induced apoptosis |
| 09/11/2002 | EP1238094A1 Method for the production of optically active cyanohydrins using r-oxynitrilase |
| 09/11/2002 | EP1238088A2 Insecticide targets and methods of use |
| 09/11/2002 | EP1238083A2 Rad3 orthologue-1 and uses thereof |
| 09/11/2002 | EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/11/2002 | EP1238068A1 Directed evolution of biosynthetic and biodegration pathways |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238065A2 Factor x analog with an improved ability to be actived |
| 09/11/2002 | EP1238064A2 Srik a novel cell cycle protein associated with rip3 |
| 09/11/2002 | EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 09/11/2002 | EP1238062A1 Compositions and methods for halogenation reactions |
| 09/11/2002 | EP1238048A1 Method for purifying marine mammal oil enriched in omega 3 fatty acids and compositions comprising same |
| 09/11/2002 | EP1238038A1 Environmentally friendly de-icer and anti-icer compositions |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237900A1 Subunit optimized fusion proteins |